The Law Office of Abe Shainberg is investigating the Board of Directors of American Medical Systems Holdings, Inc. (“AMS” or the “Company”) (Nasdaq: AMMD) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Endo Pharmaceuticals Holdings, Inc. (Nasdaq: ENDP). Under the terms of the proposed transaction, AMS shareholders will receive $30 in cash per share for a total transaction value of approximately $2.9 billion, including the assumption of debt.

The investigation concerns whether the AMS Board of Directors breached their fiduciary duties to AMS stockholders by failing to adequately shop the Company before entering into this transaction and whether Endo is underpaying for AMS shares.

If you own common stock in AMS and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at as@ashainberglaw.com or by telephone at (212) 425-7286, or visit http://www.ashainberglaw.com/american-medical-ammd.html.

Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010

If you liked this article you might like

American Medical Systems Reaches New 52-Week High (AMMD)

American Medical Systems Reaches New 52-Week High (AMMD)

American Medical Systems Reaches New 52-Week High (AMMD)

American Medical Systems Reaches New 52-Week High (AMMD)

American Medical Systems Stock Hits New 52-Week High (AMMD)

American Medical Systems Stock Hits New 52-Week High (AMMD)

American Medical Systems Reaches New 52-Week High (AMMD)

American Medical Systems Reaches New 52-Week High (AMMD)

Frito Lay's New Flavors, ETF Trends, "The New Financial Deal"

Frito Lay's New Flavors, ETF Trends, "The New Financial Deal"